CWG
TBPH icon

C WorldWide Group’s Theravance Biopharma TBPH Stock Holding History

C WorldWide Group’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-11,987
Closed -$179K – 140
2014
Q4 		$179K Sell
11,987
-9,870
-45% -$172K ﹤0.01% 116
2014
Q3 		$518K Buy
+21,857
New +$634K 0.01% 97

Other funds holding TBPH

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FAM
Foundation Asset Management White Plains, New York $116M AUM 31.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

C WorldWide Group's TBPH Position: Q1 2015 in Review

C WorldWide Group sold out of Theravance Biopharma (TBPH) in Q1 2015, closing a stake of 11,987 shares — an estimated $179K sold.

C WorldWide Group first reported a position in TBPH in Q3 2014 and held it in 2 quarters. The position peaked at $518K in Q3 2014. 89 funds tracked by Wall St. Rank hold TBPH as of Q1 2015.

  • C WorldWide Group reported no remaining Theravance Biopharma position as of Q1 2015 after selling out during the quarter.
  • C WorldWide Group sold 11,987 Theravance Biopharma shares in Q1 2015, an estimated $179K.
  • C WorldWide Group first reported a position in Theravance Biopharma in Q3 2014 and held it in 2 quarters.
  • C WorldWide Group's Theravance Biopharma position peaked at $518K in Q3 2014.
  • 89 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2015.

Based on C WorldWide Group's 13F filing for Q1 2015, filed 13 May 2015.